KEGG   DISEASE: Graft-versus-host disease
Entry
H00084                      Disease                                
Name
Graft-versus-host disease
Description
Graft-versus-host disease (GVHD) is a lethal complication of allogeneic hematopoietic stem cell transplantation (HSCT) where immunocompetent donor T cells attack the genetically disparate host cells. GVHD pathophysiology can be summerized in a three-step process. Step 1 involves the development of an inflammatory milieu resulting from damage in the host tissues induced by the preparative chemotherapy or radiotherapy regimen. Damaged tissues secrete inflammatory cytokines, including interleukin 1 (IL-1), and tumor necrosis factor (TNF-alpha ). During step 2, antigen-presenting cells (APCs) trigger the activation of donor-derived T cells, which induce further T-cell expansion, induce cytotoxic T lymphocytes (CTL) and natural killer (NK) cells responses and prime additional mononuclear phagocytes to produce TNF-alpha and IL-1. Also, nitric oxide (NO) is produced by activated macrophages, and it may contribute to the tissue damage seen during step 3. During step 3, the effector phase, activated CTL and NK cells mediate cytotoxicity against target host cells through Fas-Fas ligand interactions and perforin-granzyme B.
Category
Immune system disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 04 Diseases of the immune system
  Certain disorders involving the immune system
   4B24  Graft-versus-host disease
    H00084  Graft-versus-host disease
Pathway-based classification of diseases [BR:br08402]
 Cellular process
  nt06535  Efferocytosis
   H00084  Graft-versus-host disease
Disease
pathway
hsa05332  Graft-versus-host disease
Pathway
hsa04630  JAK-STAT signaling pathway
Network
nt06535 Efferocytosis
Gene
IL10 [HSA:3586] [KO:K05443]
TNF [HSA:7124] [KO:K03156]
IL1A [HSA:3552] [KO:K04383]
IL1RN [HSA:3557] [KO:K05481]
IFNG [HSA:3458] [KO:K04687]
IL6 [HSA:3569] [KO:K05405]
TGFB1 [HSA:7040] [KO:K13375]
TGFB2 [HSA:7042] [KO:K13376]
TGFB3 [HSA:7043] [KO:K13377]
IL13 [HSA:3596] [KO:K05435]
TNFRSF1B [HSA:7133] [KO:K05141]
IL2 [HSA:3558] [KO:K05429]
Drug
Ruxolitinib phosphate [DR:D09960]
Ibrutinib [DR:D10223]
Abatacept [DR:D03203]
Belumosudil mesylate [DR:D11816]
Other DBs
ICD-11: 4B24
ICD-10: T86
MeSH: D006086
OMIM: 614395
Reference
  Authors
Markey KA, MacDonald KP, Hill GR
  Title
Impact of cytokine gene polymorphisms on graft-vs-host disease.
  Journal
Tissue Antigens 72:507-16 (2008)
DOI:10.1111/j.1399-0039.2008.01139.x
Reference
  Authors
Holler E.
  Title
Cytokines, viruses, and graft-versus-host disease.
  Journal
Curr Opin Hematol 9:479-84 (2002)
DOI:10.1097/00062752-200211000-00002
Reference
  Authors
Dickinson AM, Holler E.
  Title
Polymorphisms of cytokine and innate immunity genes and GVHD.
  Journal
Best Pract Res Clin Haematol 21:149-64 (2008)
DOI:10.1016/j.beha.2008.03.004
Reference
  Authors
Dickinson AM, Harrold JL, Cullup H.
  Title
Haematopoietic stem cell transplantation: can our genes predict clinical outcome?
  Journal
Expert Rev Mol Med 9:1-19 (2007)
DOI:10.1017/S1462399407000488
Reference
  Authors
Gilliam AC.
  Title
Update on graft versus host disease.
  Journal
J Invest Dermatol 123:251-7 (2004)
DOI:10.1111/j.1523-1747.2004.23211.x
Reference
PMID:14657427 (IL10)
  Authors
Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, Hansen JA
  Title
Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.
  Journal
N Engl J Med 349:2201-10 (2003)
DOI:10.1056/NEJMoa022060
LinkDB

» Japanese version

KEGG   DISEASE: Rheumatoid arthritis
Entry
H00630                      Disease                                
Name
Rheumatoid arthritis
  Subgroup
Juvenile idiopathic arthritis (JIA) [DS:H01672]
Description
Rheumatoid arthritis (RA) is a common autoimmune disease that primarily manifests as chronic inflammatory arthropathy. Persistent synovitis leads to cartilage destruction, bone erosions and periarticular decalcification, subsequently resulting in impaired joint function. It is more common between the ages of 35 and 50 years, affecting three times more women than men. Susceptibility to RA is genetically determined with multiple genes contributing. Inheritance of HLA DRB1 alleles encoding a distinctive five-amino-acid sequence known as the "shared epitope" (SE) is the best characterized genetic risk factor. The mechanism by which the SE alleles contribute to the development of RA is not very clear. It has been postulated that the presence of these conserved sequences in the antigen-binding groove alters the way antigenic peptides are bound to and presented to T-cell lymphocytes. This, in turn, may trigger abnormal immune responses and lead to RA.
Category
Immune system disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 15 Diseases of the musculoskeletal system or connective tissue
  Arthropathies
   Inflammatory arthropathies
    FA20  Rheumatoid arthritis
     H00630  Rheumatoid arthritis
Pathway-based classification of diseases [BR:br08402]
 Cellular process
  nt06535  Efferocytosis
   H00630  Rheumatoid arthritis
Disease
pathway
hsa05323  Rheumatoid arthritis
Pathway
hsa04612  Antigen processing and presentation
hsa04620  Toll-like receptor signaling pathway
hsa04625  C-type lectin receptor signaling pathway
hsa04659  Th17 cell differentiation
Network
nt06535 Efferocytosis
Gene
HLA-DRB1 [HSA:3123] [KO:K06752]
PTPN22 [HSA:26191] [KO:K18024]
CIITA [HSA:4261] [KO:K08060]
CD244 [HSA:51744] [KO:K06582]
SLC22A4 [HSA:6583] [KO:K08202]
IRF5 [HSA:3663] [KO:K09446]
NFKBIL1 [HSA:4795] [KO:K09256]
IL10 [HSA:3586] [KO:K05443]
(JIA) IL6 [HSA:3569] [KO:K05405]
(JIA) MIF [HSA:4282] [KO:K07253]
Drug
Triamcinolone acetonide [DR:D00983]
Dexamethasone [DR:D00292]
Dexamethasone sodium phosphate [DR:D00975]
Hydrocortisone [DR:D00088]
Hydrocortisone sodium succinate [DR:D00978]
Prednisolone [DR:D00472]
Prednisolone sodium phosphate [DR:D00981]
Prednisone [DR:D00473]
Sulfasalazine [DR:D00448]
Indomethacin [DR:D00141]
Methylprednisolone [DR:D00407]
Methylprednisolone sodium succinate [DR:D00751]
Methylprednisolone acetate [DR:D00979]
Naproxen [DR:D00118]
Naproxen sodium [DR:D00970]
Corticotropin [DR:D00146]
Cortisone acetate [DR:D00973]
Methotrexate [DR:D00142]
Methotrexate sodium [DR:D02115]
Rituximab [DR:D02994]
Celecoxib [DR:D00567]
Abatacept [DR:D03203]
Etanercept [DR:D00742]
Infliximab [DR:D02598]
Adalimumab [DR:D02597]
Certolizumab pegol [DR:D03441]
Golimumab [DR:D04358]
Anakinra [DR:D02934]
Tocilizumab [DR:D02596]
Sarilumab [DR:D10161]
Cyclosporine [DR:D00184]
Tofacitinib citrate [DR:D09783]
Baricitinib [DR:D10308]
Upadacitinib hydrate [DR:D11048]
Leflunomide [DR:D00749]
Azathioprine [DR:D00238]
Diclofenac sodium and misoprostol [DR:D11091]
Piroxicam [DR:D00127]
Fenoprofen calcium [DR:D00968]
Flurbiprofen [DR:D00330]
Oxaprozin [DR:D00463]
Ibuprofen and famotidine [DR:D11575]
Naproxen and esomeprazole magnesium [DR:D11576]
Meclofenamate sodium [DR:D00169]
Auranofin [DR:D00237]
Salsalate [DR:D00428]
Hydroxychloroquine sulfate [DR:D02114]
Lobenzarit sodium [DR:D01808]
Other DBs
ICD-11: FA20
ICD-10: M05
MeSH: D001172
OMIM: 180300 604302
Reference
  Authors
Chung IM, Ketharnathan S, Thiruvengadam M, Rajakumar G
  Title
Rheumatoid Arthritis: The Stride from Research to Clinical Practice.
  Journal
Int J Mol Sci 17:E900 (2016)
DOI:10.3390/ijms17060900
Reference
  Authors
Boissier MC, Semerano L, Challal S, Saidenberg-Kermanac'h N, Falgarone G
  Title
Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction.
  Journal
J Autoimmun 39:222-8 (2012)
DOI:10.1016/j.jaut.2012.05.021
Reference
  Authors
Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K
  Title
An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis.
  Journal
Nat Genet 35:341-8 (2003)
DOI:10.1038/ng1267
Reference
  Authors
Dawidowicz K, Allanore Y, Guedj M, Pierlot C, Bombardieri S, Balsa A, Westhovens R, Barrera P, Alves H, Teixeira VH, Petit-Teixeira E, van de Putte L, van Riel P, Prum B, Bardin T, Meyer O, Cornelis F, Dieude P
  Title
The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype.
  Journal
Ann Rheum Dis 70:117-21 (2011)
DOI:10.1136/ard.2010.129171
Reference
  Authors
Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Sninsky JJ, Gregersen PK
  Title
A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.
  Journal
Am J Hum Genet 75:330-7 (2004)
DOI:10.1086/422827
Reference
  Authors
Marinou I, Healy J, Mewar D, Moore DJ, Dickson MC, Binks MH, Montgomery DS, Walters K, Wilson AG
  Title
Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status.
  Journal
Arthritis Rheum 56:2549-56 (2007)
DOI:10.1002/art.22814
Reference
  Authors
Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M, Lobell A, Khademi M, Borjesson O, Lindgren CM, Lundman P, Brookes AJ, Kere J, Luthman H, Alfredsson L, Hillert J, Klareskog L, Hamsten A, Piehl F, Olsson T
  Title
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
  Journal
Nat Genet 37:486-94 (2005)
DOI:10.1038/ng1544
Reference
  Authors
Okamoto K, Makino S, Yoshikawa Y, Takaki A, Nagatsuka Y, Ota M, Tamiya G, Kimura A, Bahram S, Inoko H
  Title
Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis.
  Journal
Am J Hum Genet 72:303-12 (2003)
DOI:10.1086/346067
Reference
  Authors
Suzuki A, Yamada R, Kochi Y, Sawada T, Okada Y, Matsuda K, Kamatani Y, Mori M, Shimane K, Hirabayashi Y, Takahashi A, Tsunoda T, Miyatake A, Kubo M, Kamatani N, Nakamura Y, Yamamoto K
  Title
Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population.
  Journal
Nat Genet 40:1224-9 (2008)
DOI:10.1038/ng.205
LinkDB

» Japanese version

DBGET integrated database retrieval system